Frost & Sullivan: Clinical Diagnostics & Research Tools
Next Generation Diagnostics program provides a truly end-to-end perspective analysis of ‘white space’ opportunities across IVD and Genomics markets. It enables companies to stay ahead of the shift to Direct to Consumer testing, track investments in Biomarkers (companion diagnostics) and adapt new business models in Clinical Laboratory services and Lab Automation markets.
Know anyone building innovative solutions that belong in this 'Clinical Diagnostics & Research Tools'?
Don't miss NextGen Omics US 2024, a two-day event uniting top omics experts and researchers to explore therapeutic innovation, NGS, clinical diagnostics, multi-omics, and single-cell analyses. Now in its 9th year, this gathering features leaders sharing novel case studies, pioneering data, and industry insights. Join global academia, research entities, and pharma representatives for high-level discussions, fostering collaboration and innovation. Mark your calendar to be part of this pivotal event shaping the future of omics technologies.
[Read on oxfordglobal.com](https://oxfordglobal.com/nextgen-omics-series-us/?utm_campaign=Omics%20Series&utm_source=listingsite&utm_medium=eventlisting&utm_content=ngous2024)
The NextGen Omics 2023 Conference brings together a panel of leaders and scientists, sharing new case studies, innovative data and industry outlook. NextGen Omics 2023 features 4 outstanding programmes, bringing together Europe’s most successful omics research experts under one roof. The series provides an excellent networking platform which consists of key discussion topics in: Next Generation Sequencing & Clinical Diagnostics, Single Cell & Spatial Analysis, Synthetic Biology in Discovery & Therapeutics and Digital PCR & Liquid Biopsies. Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.
Join us at the 5th International Qserve MedTech Conference, where a very diverse program will be presented by Qserve’s internal hosts and with speakers from the industry, Notified Bodies, and Competent Authorities .The theme of the conference, ‘achieving full compliance,’ will address 25 years of sharing global knowledge and the expertise we bring to the field in guiding processes in the regulatory industry toward full compliance. The conference will include updates on the EU regulations, changes in the US and China regulations, and discuss worldwide registrations based on EU or US approval. Qserve MedTech helps to improve patient safety and health by supporting the advancement of biomedical technology. Qserve MedTech assist medical device and in-vitro diagnostics manufacturers worldwide with market access, medical device approvals, clinical trials and achieving and maintaining regulatory compliance.
Parallel tracks for medical devices and in vitro diagnostic manufacturers
Focus on market access in Europe & United States
Extra focus on clinical subjects like clinical studies, clinical evaluation, and PMCF
40+ expert speakers from Qserve, the industry, and Notified Bodies
The Innovation in Clinical Trials 2023 Conference brings together leaders and scientists, sharing case studies, data and industry outlook. Join and network with over 150 industry leaders, innovative speakers and participants to share ideas and best practices, co-create solutions, and empower teams & individuals to drive forward innovation in clinical trials. Benefits to Attending are “Bringing together over 150 prominent leaders” in leading pharma companies and healthcare institutions: Benchmarking Innovation In Clinical Trials, Implementing Decentralized Clinical Trials and Conducting Sustainable Patient Centric Clinical Trials, “An informative two-day meeting” to accelerate innovation in clinical trials spanning the areas of benchmarking, decentralization, digital approaches, regulatory considerations and sustainability, “Engage in scientific discussions” through interactive panels and roundtables; key sessions include the carbon footprint of clinical trials and conducting sustainable clinical trials and “A showcase of the latest technological developments” in clinical trial management, R&D, sustainability in Data/AI.
In vitro diagnostics (IVDs) play a key role in today’s healthcare system. Their importance has been strongly highlighted in the global effort to combat and control the spread of SARS-CoV-2, the virus …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our